Wednesday 31 October 2012 2:17pm
Professor Brett Delahunt, from the Department of Pathology and Molecular Medicine, has been elected as a Fellow of the Royal Society of New Zealand at the recent Annual General Meeting for his exceptional distinction in research and the advancement of medical science.
Professor Brett Delahunt is acknowledged as an international authority in the field of urological pathology. His many scientific contributions, focussing on the characterisation, classification and outcome assessment of renal neoplasms and prostate cancer have had an important impact on patient management.
He has characterised several novel forms of renal neoplasia, and has been a major contributor to the identification of prognostic markers that facilitate better management and allow prediction of outcome in individual cases. In March of this year he chaired a major international consensus conference in Vancouver, Canada that formally reclassified the various types of renal malignancy. At the meeting a novel grading classification for renal carcinomas was also formulated.
His contributions have led to his election as President of the International Society of Urological Pathology as well as his appointment to the World Health Organisation Classification Panel for Male Genital and Urological Tumours, and the Expert Panel for Tumour Staging of the Union Internationale Contre le Cancer.
